An interventional study of Baseline and Sleep restriction in Obesity and Diabetes, sponsored by University of Chicago. Completed at 1 site in United States. Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2013-09-05.
Sponsored by University of Chicago · Not applicable and Interventional
This study is designed to study the pathways through which short sleep duration or poor sleep quality can lead to an increased risk of developing diabetes and obesity.
6,296 studies on the registry are indexed under Obesity; 1,692 are open to participants now.
This study's enrollment of 23 is below the median of 78 across 4,878 interventional studies indexed under Obesity.
Browse Obesity studies →University of Chicago is the lead sponsor of 907 studies on the registry; 182 are open to participants now.
Of its 99 completed or terminated interventional studies of FDA-regulated products, 68 (69%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Subjects are tested under normal sleep conditions for carbohydrate metabolism and appetite regulation.
Other: Baseline
Subjects are tested under sleep restriction for carbohydrate metabolism and appetite regulation.
Other: Sleep restriction
Subjects are tested under a poor sleep quality condition for carbohydrate metabolism and appetite regulation.
Other: Reduced Sleep Quality
Subjects are allowed time in bed for sleep as their usual time at home.
Subjects sleep is reduced to 4.5 hours in bed for 4 nights.
Subjects sleep quality is reduced for 4 nights.
Disposition Index reflecting Diabetes Risk as a result of decreased sleep duration and/or quality.
Time frame: 3 months
This study is completed, as verified in Sep 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Chicago